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Abstract 1 
 2 
Omega-3 fatty acids are associated with better cardiovascular and cognitive health. However, the 3 
concentration of EPA, DPA and DHA in different plasma lipid pools differs and factors influencing 4 
this heterogeneity are poorly understood. Our aim was to evaluate the association of oily fish intake, 5 
sex, age, BMI and APOE genotype with concentrations of EPA, DPA and DHA in plasma PC, 6 
NEFAs, CEs and TGs. Healthy adults (148 male, 158 female, age 20-71 years) were recruited 7 
according to APOE genotype, sex and age. Fatty acid composition was determined by gas 8 
chromatography. Oily fish intake was positively associated with EPA in PC, CEs and TGs, DPA in 9 
TGs, and DHA in all fractions (P < 0.008). There was a positive association between age and EPA 10 
in PC, CEs and TGs, DPA in NEFAs and CEs, and DHA in PC and CEs (P < 0.034). DPA was 11 
higher in TGs in males than females (P < 0.001). There was a positive association between BMI 12 
and DPA and DHA in TGs (P < 0.006 and 0.02, respectively). APOE genotype*sex interactions 13 
were observed: the APOE4 allele associated with higher EPA in males (P = 0.002), and there was 14 
also evidence for higher DPA and DHA (P < 0.032). In conclusion, EPA, DPA and DHA in plasma 15 
lipids are associated with oily fish intake, sex, age, BMI, and APOE genotype. Such insights may be 16 
used to better understand the link between plasma fatty acid profiles and dietary exposure and may 17 
influence intake recommendations across population subgroups.  18 
 19 
 20 
 21 
 22 
Keywords: apolipoprotein E (APOE) genotype; oily fish intake; omega 3 status; n-3 long chain 23 
polyunsaturated fatty acids; eicosapentaenoic acid (EPA); docosahexaenoic acid (DHA); fatty acid 24 
status; blood lipids.  25 
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Introduction 26 
There is convincing evidence that higher intakes of the marine long chain n-3 PUFAs (LC n-27 
3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are beneficial to 28 
cardiovascular and cognitive health, acting through a number of biological mechanisms, and that 29 
the concentration of EPA and DHA present in blood and tissue lipids is correlated positively with 30 
these effects 1-5. Oily fish are a good source of EPA and DHA; therefore, national and international 31 
authorities recommend regular consumption of oily fish such as salmon, mackerel, kippers, sardines, 32 
herring, trout and fresh tuna, in order to provide approximately 500 mg EPA+DHA per day 6, with 33 
higher intakes of LC n-3 PUFAs recommended for those with diagnosed cardiovascular disease 7. 34 
However, the associations between intake and blood and tissue status, and therefore physiological 35 
benefits, are highly variable 8, and the factors influencing this heterogeneity are not well understood. 36 
A greater knowledge of determinants of LC n-3 PUFA status could lead to the development of more 37 
robust, and perhaps subgroup specific, recommendations for EPA and DHA intake.  38 
In addition to intake of the specific LC n-3 PUFAs and their precursors, the heterogeneity in 39 
habitual EPA, docosapentaenoic acid (DPA) and DHA concentrations may be influenced by 40 
differences in fatty acid metabolism between sexes; females are reported to synthesise EPA, DPA 41 
and DHA from shorter chain n-3 fatty acids more readily than males 9-13. Lipid metabolism alters 42 
with age and becomes dysregulated in obesity, and EPA and DHA concentrations have been 43 
reported to be affected by increasing BMI 12 14 as well as with age 10-12. Apolipoprotein E (APOE) 44 
genotype is associated with altered lipid metabolism and transport, with differential responses in 45 
APOE4 carriers relative to non-carrier groups 12 14. Recent reports highlight the importance of 46 
APOE genotype in the response of EPA and DHA to supplementation and have indicated 47 
interactions between genotype and BMI 14. In addition, the concentrations of LC n-3 PUFAs in 48 
individual lipid pools within blood (and in other tissues) differs 15. However, despite these insights 49 
from the published literature, the influence of oily fish intake, along with sex, age, BMI and APOE 50 
genotype on EPA, DPA and DHA concentrations in different plasma pools has not been examined 51 
systematically. Using samples from the FINGEN study 4, where participants were prospectively 52 
recruited based on a number of these variables (sex, age, and APOE genotype), we have conducted 53 
such an analysis in a large number of participants to evaluate the independent and interactive impact 54 
of a number of potential determinants (oily fish intake, sex, age, BMI and APOE genotype) on EPA, 55 
DPA and DHA concentrations in the main plasma lipid fractions.  56 
 57 
Participants and methods 58 
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The FINGEN study was a multi-centre trial conducted at the Universities of Glasgow, 59 
Newcastle, Reading and Southampton in the United Kingdom. Three hundred and twelve 60 
participants were recruited prospectively on the basis of APOE genotype (87 were APOE2 61 
homozygotes or APOE2/APOE3, 111 were homozygous for APOE3, and 114 were APOE4/APOE3 62 
or APOE4 homozygotes), sex (149 male and 163 female) and age (20 to 71 years, with 63 
approximately equal numbers in each of the 5 decades) 4. Data from 306 participants were included 64 
in the current analysis, with the numbers in each subgroup detailed in Supplemental Table 1 and 65 
Supplemental Table 2. Exclusion criteria included: diagnosed endocrine dysfunction including 66 
diabetes or fasting glucose concentration > 6.5 mmol/L, myocardial infarction in the previous 2 67 
years, the use of medication that may interfere with lipid metabolism, fasting total cholesterol of > 68 
8.0 mmol/L or TG of > 3.0 mmol/L, a BMI of < 18.5 or > 36.0 kg/m2, or currently following a 69 
weight loss diet. Individuals taking n-3 fatty acid supplements were also excluded. The study was 70 
approved by the research ethics committee at each of the participating centres and written informed 71 
consent was obtained from all subjects prior to participation.  72 
 73 
Study design  74 
The FINGEN study was a randomised double blind, placebo controlled, crossover study 75 
testing two doses of fish oil compared with placebo 4. Here we evaluate the association of oily fish 76 
intake, sex, age, BMI and APOE genotype with fasting concentrations of EPA, DPA and DHA in 77 
plasma phosphatidylcholine (PC), non-esterified fatty acids (NEFAs), cholesteryl esters (CEs) and 78 
triacylglycerols (TGs) at baseline, prior to intervention. Habitual oily fish intake was estimated by 79 
food frequency questionnaire (FFQ), using self-reported portions completed at baseline. Oily fish 80 
was defined as salmon, herring, mackerel, fresh tuna, sardines, kippers, and trout.  81 
 82 
Fatty acid analysis 83 
The fatty acid composition of the plasma fractions was determined by gas chromatography. 84 
Dipentadecanoyl PC, heneicosanoic acid, cholesteryl heptadecanoate and tripentadecanoin internal 85 
standards were added to the plasma. Total plasma lipid was extracted using chloroform: methanol 86 
(2:1, v/v) containing butylated hydroxytoluene (50 mg/L) as described by Folch et al 16, and PC, 87 
NEFA, CE and TG fractions were separated and isolated by solid phase extraction on aminopropyl 88 
silica cartridges. CEs and TGs were eluted in a combined fraction with the addition of chloroform. 89 
PC was then eluted from the cartridge with the addition of chloroform: methanol (60:40 v/v). 90 
NEFAs were eluted from the cartridge with the addition of chloroform: methanol: glacial acetic acid 91 
(100:2:2 v/v). CEs and TGs were separated on a hexane primed aminopropyl silica cartridge with 92 
the addition of hexane to elute CEs, and the addition of hexane: methanol: ethyl acetate (100:5:5 93 
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v/v/v) to elute TGs. The fatty acids within the resulting lipid fractions were methylated by the 94 
addition of methanol in 2% (v/v) sulphuric acid at 50°C for 2 hours to produce fatty acid methyl 95 
esters (FAMEs) 17. FAMEs were extracted into hexane and separated in a BPX-70 fused silica 96 
capillary column (30 m × 0·25 mm × 25 μm; SGE Analytical Science, United Kingdom) using an 97 
Agilent 6890 series gas chromatograph equipped with flame ionisation detection (Agilent 98 
Technologies, California, United States). The FAMEs were identified by comparison with retention 99 
times of 37 FAME and menhaden oil standards run alongside the samples, and quantified with the 100 
use of the internal standards using ChemStation software (Agilent Technologies, California, United 101 
States) and Microsoft Excel (Microsoft Corporation, Washington, United States). Fatty acid 102 
composition data are expressed as absolute concentrations (µg/ml plasma) and as relative 103 
concentrations (g/100 g total fatty acid (%)). 104 
 105 
Statistics 106 
Here we report baseline data obtained as part of the previous FINGEN trial4. Characteristics 107 
for participants included in the baseline analysis are detailed in Supplemental Table 1 and 108 
Supplemental Table 2.  109 
Results for the relative (%) and absolute concentrations (µg/ml) of fatty acids are reported 110 
for 303 to 306 and 292 to 306 participants in the four plasma lipid fractions. Data were checked for 111 
normality by plotting distributions of residuals obtained from general linear model (GLM) analysis 112 
of the data, and were analysed appropriately with a univariate GLM following log10 transformation. 113 
All variables were included in the univariate model with individual associations analysed using 114 
‘main effects’ and interaction between age and BMI, age and fish intake, and sex and APOE 115 
analysed using ‘interaction’ analysis options within the model. P values were corrected for multiple 116 
analyses using Bonferroni post hoc analysis resulting in a significance value of P = 0.006 for whole 117 
group analysis and P = 0.008 for analyses where males and females were analysed separately. All 118 
statistical analyses were conducted using SPSS software (version 21; SPSS Inc, Chicago, IL). 119 
Statistical significance was defined as P < 0.05. Results are expressed as mean ± SEM or median 120 
(25th, 75th percentiles).  121 
 122 
Results  123 
The group (n = 306) mean age and BMI was 45.1 ± 0.7 y and 25.2 ± 0.2 kg/m2, respectively.   124 
 125 
Male and female participants were well matched for age, but males had a significantly higher 126 
average BMI (P < 0.001, Supplemental Table 1 and Supplemental Table 2). There were no sex 127 
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differences in the proportion of total dietary energy consumed from fat, saturated fat (SFA), 128 
monounsaturated fat (MUFA) or polyunsaturated fat (PUFA) (data not shown). The average oily 129 
fish intake was 1.0 portion per week with no association of sex with oily fish intake. 130 
 131 
For all three LC n-3 PUFAs, the greatest concentrations were evident in the PC fraction, with 132 
median absolute concentrations (µg/ml) of 15.1, 11.9 and 44.1 for EPA, DPA and DHA, 133 
respectively. The median values for EPA, DPA and DHA for the whole group and P values for the 134 
association of oily fish intake, sex, age, BMI and APOE with the plasma concentrations of these 135 
fatty acids in the four lipid fractions are presented in Table 1. The data according to oily fish intake 136 
are shown in Supplemental Figures 1-4, while data according to age and BMI are shown in Table 137 
2 and Supplemental Tables 3-5, and those according to APOE genotype*sex in Figures 1-3. 138 
 139 
Plasma EPA, DPA and DHA in the group as a whole 140 
 141 
EPA: The concentration of EPA in plasma CEs and TGs was positively associated with oily fish 142 
intake (P < 0.004), with evidence for positive association in plasma PC also (P = 0.018) (Table 1). 143 
There was evidence for a positive association between EPA and age in plasma PC, CE’s and TGs (P 144 
= 0.021, 0.019, and 0.034 respectively) and for the concentration of EPA in CEs to differ by sex (P 145 
= 0.055), (Table 2). A higher concentration of EPA in CEs was observed in males (Table 2), and 146 
the concentration of EPA in TGs was associated with an APOE*sex interaction (P = 0.044, data not 147 
shown).  148 
 149 
DPA: The concentration of DPA was positively associated with oily fish intake in plasma TGs (P = 150 
0.006), with evidence for positive association in plasma PC also (P = 0.022) (Table 1). DPA in TGs 151 
was positively associated with BMI (P = 0.006) (Table 1), and there was evidence for the positive 152 
association of DPA in NEFAs and CEs with age (P = 0.031 and 0.007 respectively, Table 1). The 153 
concentration of DPA significantly differed by sex with a higher concentration of DPA observed in 154 
plasma TGs in males (P <0.001), with a trend in PC also (P 0.031) (Table 1). There was also a 155 
significant APOE*sex interaction for the concentration of DPA in CEs (P < 0.005, data not shown). 156 
(Table 1), 157 
 158 
DHA: The concentration of DHA in all plasma lipid fractions was positively associated with oily 159 
fish intake (P < 0.001). There was evidence for a positive association of DHA in TGs with BMI (P 160 
= 0.020) (Table 1) and with age in PC, CEs and TGs (P = 0.037, 0.039, and 0.050 respectively, 161 
Table 1).  162 
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 163 
Overall in PC, NEFAs, CEs, and TGs, the highest oily fish consumers (2+ portions of oily fish per 164 
week) had 55%, 42%, 52% and 119% higher EPA+DHA, respectively, compared with those 165 
reporting no oily fish intake (Supplemental Figure 4).  166 
 167 
Due to the significant evidence of sex and APOE*sex interactions, subgroup analysis was 168 
performed in males and females separately. 169 
 170 
Subgroup analysis of plasma EPA, DPA and DHA according to sex 171 
 172 
Significance data (P) are reported for EPA, DPA and DHA in Table 2 and median data are reported 173 
for EPA, DPA and DHA in Supplemental Tables 3, 4, and 5 respectively. 174 
  175 
EPA (Table 2, Supplemental Table 3): The concentration of EPA in plasma TGs was positively 176 
associated with oily fish intake in both males and females (P < 0.008), while the concentration of 177 
EPA in PC was positively associated with oily fish intake in females only (P < 0.004. EPA 178 
concentration in TGs was positively associated with age and BMI in females (P = 0.006), while 179 
EPA in TGs differed by APOE genotype in males (P = 0.002), with evidence for this in CEs also (P 180 
= 0.019), (Figure 1). A greater concentration of EPA in TGs was observed in male APOE4 carriers 181 
(P = 0.002) with evidence for this in PC and CEs also (P = 0.019 and 0.053 respectively), (Figure 182 
1).   183 
 184 
DPA (Table 2, Supplemental Table 4): The concentration of DPA in plasma TGs was positively 185 
associated with oily fish intake in females (P = 0.008). There was evidence for DPA concentration 186 
in PC to differ with APOE genotype in males (P < 0.053, Figure 2) with further analysis revealing 187 
evidence for higher concentrations of DPA in PC in APOE4 allele carriers (P = 0.032, Figure 2).  188 
 189 
DHA (Table 2, Supplemental Table 5): The concentration of DHA was positively associated with 190 
oily fish intake in plasma PC, NEFAs, and TGs in females (P < 0.002) and plasma PC in males (P < 191 
0.003), (Table 2). There was evidence for DHA in plasma NEFAs to be associated with BMI in 192 
females (P = 0.010, Table 2), and for DHA in CEs to differ by APOE genotype in males. Further 193 
analysis revealed evidence for a higher concentration of DHA in CEs in APOE4 carriers (P = 0.021, 194 
Figure 3). 195 
 196 
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Discussion 197 
EPA and DHA have been widely reported for their beneficial effects on cardiovascular and 198 
cognitive health 1-4 18 but a high level of variation in associations between intake and blood and 199 
tissue status has been observed 8. The current analysis aimed to identify factors associated with 200 
concentrations of EPA, DPA and DHA in major lipid fractions in plasma from individuals 201 
consuming their usual diet in order to identify sources of variation in these concentrations. 202 
Identification of the contribution that oily fish intake, sex, age, BMI and APOE genotype make to 203 
EPA, DPA and DHA status is important for two reasons. First it will highlight the sources of the 204 
heterogeneity in status of these fatty acids, contributing to a better understanding of the use of fatty 205 
acid profiles as a measure of dietary intake amongst different population subgroups. Secondly, it 206 
may allow the development of sub-group specific recommendations for LC n-3 PUFA intake.  207 
The current study reports associations for multiple confounding variables with the relative 208 
and absolute concentrations of EPA, DPA and DHA in different plasma lipids. The relative 209 
concentration allows investigation of LC n-3 PUFA concentrations in relation to all other fatty acids 210 
within the plasma pool (% unit changes), while the absolute concentration allows investigation of 211 
µg/ml unit changes in LC n-3 PUFAs independently of any other fatty acid within the plasma pool. 212 
Both ways of expressing the data are useful and informative and both are used in the literature in the 213 
field. The absolute concentration of a fatty acid within any plasma lipid fraction will be influenced 214 
by the total concentration of that fraction. The absolute concentration of a particular fatty acid may 215 
differ between individuals or between sub-groups while the relative concentration of that fatty acid 216 
may not be different between those individuals or sub-groups. Conversely, the relative 217 
concentration could be different but the absolute concentration may not be. Plasma lipids are 218 
involved in transport of fatty acids between tissues where they have different actions depending 219 
upon their structure. Hence, the absolute concentration of a fatty acid in a plasma lipid reflects the 220 
exposure of tissues to that fatty acid and hence is likely to be a meaningful way of reporting the 221 
fatty acid. Conversely, fatty acids often compete with one another for metabolism or for function 222 
and hence the relative concentration of each fatty acid (i.e. %) is also likely to be meaningful.  223 
Quantitatively, PC is the main plasma LC n-3 PUFA pool and the current study reports a 224 
greater relative concentration of EPA+DHA in plasma PC (Supplemental Figure 4) in individuals 225 
consuming 2+ portions of oily fish a week compared to those who reported not consuming oily fish, 226 
as well as positive associations between EPA, DPA and DHA in other plasma lipid fractions and 227 
oily fish intake. Positive associations for oily fish intake and EPA and DHA are reported for plasma 228 
phospholipids 19-21 which are confirmed by data from the current analysis which shows 55% higher 229 
EPA+DHA in plasma PC in those consuming two portions of oily fish (each 150 g) per week 230 
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compared with those reporting no oily fish consumption. Two portions of oily fish supply about 4-5 231 
g of EPA+DHA per week, equivalent to 600-700 mg per day22 23. Previous studies report 232 
comparable increases of 81% in plasma phospholipid EPA+DHA, and 8.8 µg/ml and 8.5 µg/ml in 233 
total plasma EPA and DHA respectively following 16 week consumption of oily fish providing 485 234 
mg EPA+DHA per day 20 and 6 week consumption of oily fish providing 927 mg EPA+DHA per 235 
day, respectively21. Overall, the findings of the current analysis support existing reports that oily 236 
fish intake is associated with, and at a population level is the main determinant of, LC n-3 PUFAs 237 
in all major blood lipid pools, which may therefore be used as biomarkers of oily fish intake 4 19 24 25. 238 
Our analysis does not clearly indicate which plasma lipid fraction would best reflect dietary intake 239 
of EPA and DHA, since, in general all four plasma lipid fractions showed dose-dependent increases 240 
in EPA and DHA concentration (both absolute and relative) with increasing frequency of oily fish 241 
consumption. 242 
There is some evidence that age influences the concentration of EPA and DHA in various 243 
plasma fatty acid fractions, 10 which has been attributed in part to higher habitual fish intake with 244 
increasing age. Oily fish intake was controlled for in the current statistical analysis, allowing clearer 245 
attribution of any observed associations of age with EPA, DPA and DHA concentrations to altered 246 
metabolism and not to dietary differences in intakes of oily fish. Any influence of APOE group 247 
distribution was also ruled out as, despite a greater number of individuals aged 50-59 yr being 248 
included in the current analysis, there was no significant difference in the distribution of APO E2, 249 
E3 and E4 genotypes between age groups (data not shown). A 28 d stable isotope tracer study in 250 
young (mean age 27 y) vs older (mean age 77 y) adults reported a 1-2 fold greater enrichment of 251 
13C–DHA in plasma phospholipids and CEs in the older age group, suggesting a medium term age-252 
related difference in DHA homeostasis associated with accumulation of DHA in the circulation in 253 
older people 26. The findings of the current analysis support reports of increased plasma DHA with 254 
increasing age 11 27 28 and we further also report positive associations between age and EPA and 255 
DPA, suggesting LC n-3 PUFAs accumulate in plasma pools during ageing. However, this may in 256 
part be due to an increase in circulating cholesterol and CE with age (Table 3). Evidence of positive 257 
associations of plasma total cholesterol with age dates back to the late 1970s 29, and these have been 258 
reported in both males and females 30. Increased circulating LDL (Table 3) may be reflected in 259 
higher absolute total PC and CE concentrations with age (P = 0.008 and 0.018, age 20-29 vs 60+ yr 260 
for PC and CE respectively, data not shown) and we observed that total cholesterol (TC) and LDL-261 
cholesterol (LDLC) concentrations were significantly positively correlated with LC n-3 PUFA 262 
concentrations in PC (TC, P = <0.001, 0.003, 0.027; LDLC P = <0.001, <0.001, 0.003, absolute 263 
EPA, DPA and DHA respectively, data not shown), and that TC, LDLC and high density 264 
lipoprotein cholesterol (HDLC) concentrations were positively correlated with LC n-3 PUFA in 265 
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CEs (TC, P = <0.001, 0.002 absolute EPA and DHA respectively, LDL, P = <0.001, 0.046, 0.055 266 
absolute EPA, relative DPA and DHA respectively, HDLC, P = 0.046 relative DPA, data not 267 
shown). These data suggest CE levels may play a significant role in the association of age with LC 268 
n-3 PUFAs reported in this analysis. 269 
Insulin has a role in the regulation of genes involved in whole body lipid homeostasis 270 
including in the  removal of lipids from the circulation31; in cases of insulin resistance, such 271 
removal can be compromised. The occurrence of insulin resistance is reported to rise with 272 
increasing age and BMl and despite individuals with diabetes or a fasting glucose concentration > 273 
6.5 mmol/L being excluded from the current analysis, differences in fasting glucose were still 274 
evident between age and BMI groups (glucose positively correlated with age and BMI; P <0.001 275 
both, data not shown). Thus, insulin resistance may contribute to the higher EPA and DPA 276 
concentrations in plasma lipid pools observed with increasing age and BMI.  277 
Increasing body fatness and obesity influence many aspects of fatty acid and lipid 278 
metabolism and contribute to disease states such as hypertriglyceridemia, diabetes, and fatty liver 279 
disease 12 32; loss of insulin sensitivity with increasing adiposity results in adipose tissue lipolysis 280 
and associated higher plasma NEFA concentrations 32-34. In the current analysis, there was no 281 
correlation between total NEFA concentrations and BMI (data not shown); however, significant, but 282 
complex, associations between BMI and LC n-3 PUFAs were evident in plasma TGs, with an 283 
overall trend towards lower relative concentrations of EPA and DHA with increasing BMI, which is 284 
consistent with previous observations 33 35. Increased β-oxidation of DHA associated with increased 285 
BMI may in part explain lower proportions of LC n-3 PUFAs in TGs 36 although altered TG 286 
synthesis and/or selective tissue uptake and partitioning in obesity may also be involved. We 287 
observed no association of BMI with absolute plasma concentrations of LC n-3 PUFAs and suggest 288 
the lower relative concentrations (i.e., %) of EPA and DHA are likely to be offset by increases in 289 
total TG concentrations with increasing BMI.  290 
The proteins encoded by the APOE gene play a major role in the transport and metabolism 291 
of lipids via interaction with LDL receptors (LDLRs). Two common polymorphisms (rs7412 and 292 
rs429358) of the APOE gene in humans result in three protein isoforms, APOE2, E3 and E4. 293 
APOE2 and APOE3 are found in the circulation mainly on high density lipoproteins (HDLs) 294 
whereas APOE4 is found preferentially on very low density lipoproteins (VLDLs) with lower 295 
concentrations residing on HDLs 37. The APOE4 allele has been associated with reduced longevity 296 
38, and enhanced risk of cardiovascular disease 39 and Alzheimer’s disease 40. Although centrally 297 
involved in fatty acid transport and handling in plasma and tissues (and in particular within the 298 
brain where APOE is almost the only apolipoprotein present), the impact of APOE genotype on 299 
these processes, and the contribution of dysregulated EPA and DHA metabolism to disease risk is 300 
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unknown. However, 13C–DHA labelling studies provide evidence that DHA metabolism is 301 
disturbed in those who are APOE4 carriers 41.  302 
In the current analysis, APOE4 carriers had significantly higher concentrations of TC and 303 
HDLC, and lower concentrations of LDLC (Table 3); however, sex*APOE genotype interactions 304 
were evident and in male APOE4 carriers we observed to have significantly higher concentrations 305 
of LDLC as well as of total CEs (data not shown). One advantage of investigating associations in 306 
individual plasma lipid classes as opposed to total lipid is that possible effects of APOE and 307 
lipoprotein transport and metabolism may be more easily identified. If the associations between 308 
APOE and LC n-3 PUFAs are seen to occur in lipid pools which are predominantly related to LDL 309 
and VLDL particles, they may reflect the dysregulation in lipoprotein handling in people with the 310 
E4 allele. However, if the associations between LC n-3 PUFA and APOE genotype are seen to 311 
occur across all lipid pools, they may be indicative of alternative mechanisms. Further subgroup 312 
analysis indicated higher EPA, DPA and DHA concentrations in CEs, EPA and DPA in PC, and 313 
EPA in TGs in male APOE4 carriers relative to the non-carrier groups. The higher EPA and DHA 314 
may reflect higher overall CE and PC concentrations; however, the lack of association between 315 
APOE genotype and fatty acid concentrations in females is suggestive of a sex specific association 316 
independent of CE and PC metabolism.  317 
Interestingly, we have previously reported APOE genotype mediated differences in the 318 
response of plasma EPA and DHA to a fish oil supplement given over eight weeks in males, with 319 
lower enrichment in total lipid and phospholipid EPA and DHA in APOE4 carriers relative to the 320 
wild-type APOE3/E3 genotype, but only in overweight participants 14. The aetiology of these 321 
associations with LC n-3 PUFA metabolism is currently unknown. As with the association with age, 322 
higher plasma LC n-3 PUFAs in APOE4 carriers may reflect reduced tissue uptake and DHA 323 
accumulating in the circulation. Although lower overall concentrations of APOE were observed in 324 
APOE4 carriers (data not shown) no difference in plasma APOE concentrations were evident 325 
between sexes, which potentially could have contributed to the differential associations of APOE 326 
genotype with EPA, DPA and DHA concentrations. The preferential binding of VLDL by APOE4 327 
and possible associations of APOE genotype with PC and CE synthesis and cellular uptake of EPA 328 
and DHA via the LDLR family, LDLR concentrations and specific LC PUFA transporters such as 329 
the MFSD2A transporter in the brain 42 may be involved, and are worthy of future investigations. 330 
Associations between sex and the activity of these transporters and receptors would also be of 331 
interest, along with sex and APOE associations with FADS and ELOVL genes which encode 332 
desaturation and elongation enzymes required for the synthesis of LC n-3 PUFAs. Differential 333 
synthesis of EPA and DHA has been reported between sexes; Pawlosky et al report greater ability 334 
of females to convert ALA to DHA through increased conversion of DPA to DHA compared to 335 
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males when consuming a beef based diet. These results were not observed when consuming a fish 336 
based diet in which the capacity to convert DPA to DHA was equal between males and females. 337 
These findings suggest LC n-3 PUFA metabolism in females may be more sensitive to dietary 338 
alterations or may be affected by hormonal regulation43. Indeed there is evidence for up-regulation 339 
of the desaturase-elongase pathway via oestrogenic actions resulting in increased conversion of 340 
ALA to EPA19 44 45 and to DHA11 13 46 indicating significant effects of female sex hormones on the 341 
metabolism of LC n-3 PUFAs. Consistent with these observations, there is evidence for an increase 342 
in DHA in relation to EPA and DPA at baseline and in response to EPA+DHA intake in females 343 
compared to males 47 48. The current analysis further reports lower concentrations of both DPA (-344 
36% lower absolute concentration in TGs) and EPA (20% lower absolute concentration in TGs) in 345 
females but does not report higher concentrations of DHA in females or find a significant effect of 346 
sex on the ratio of DPA: DHA (P >0.50, data not shown). However, these results are also in 347 
contrast to other reports describing increased concentrations of EPA and DHA in females 19 44 45. 348 
These data from the current analysis suggest investigation into associations between sex, APOE, 349 
and fatty acid synthesis enzymes and transporters would be of worthwhile to further understand the 350 
mechanisms by which these associations occur.  351 
 352 
In conclusion, we report concentrations of EPA, DPA and DHA to vary across APOE 353 
genotype and that sex is an important factor to consider when evaluating LC n-3 PUFA 354 
concentrations in these genotypic subgroups. Our results also confirm that concentrations of EPA, 355 
DPA and DHA in plasma pools are suitable population markers of oily fish consumption and show 356 
that age and sex are important contributors to the variation in EPA, DPA and DHA concentrations 357 
in plasma lipids independent of APOE genotype. These variables should be considered when 358 
interpreting LC n-3 PUFA concentrations as a marker of dietary intake and when suggesting dietary 359 
LC n-3 PUFA recommendations to ensure benefits are achieved across population subgroups. 360 
Investigation into the handling of supplemental EPA and DHA in these subgroups is to be 361 
addressed in a further publication and could provide the basis for more detailed advice. However, 362 
the aetiology and physiological significance of the interaction between sex and APOE genotype and 363 
its association with EPA, DPA and DHA status still requires further investigation.  364 
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Table 1 
Median EPA, DPA, and DHA in the plasma lipid fractions and statistical significance (P) of the association of oily fish intake, sex, age, and BMI 
on absolute and relative concentrations of these LC n-3 PUFAs1  
 
                                                                                       EPA 
 
PC NEFAs CEs TGs 
 
PC NEFAs CEs TGs 
 
(P) (P) (P) (P) 
 
(P) (P) (P) (P) 
  % %   % %   μg/ml μg/ml    μg/ml μg/ml 
Median  1.01 0.43 0.77 0.42 
 
15.14 0.85 14.2 2.98 
(25th, 75th percentile) (0.65, 1.57) (0.26, 0.66) (0.46, 1.10) (0.27, 0.65)   (8.74, 23.23) (0.48, 1.47) (8.45, 23.45) (1.83, 4.72) 
Oily Fish Intake2  0.055 - 0.004 <0.001 
 
0.018 - 0.058 <0.001 
Sex  - - 0.055 - 
 
- - - - 
Age3  0.063 - - - 
 
0.021 - 0.019 0.034 
BMI4  - - - 0.041   - - - - 
 
                                                                                           DPA 
 
PC NEFAs CEs TGs 
 
PC NEFAs CEs TGs 
 
(P) (P) (P) (P) 
 
(P) (P) (P) (P) 
  % % % %   μg/ml μg/ml μg/ml μg/ml 
Median  0.78 0.31 0.07 0.33 
 
11.87 0.62 1.34 2.32 
(25th, 75th percentile) (0.55, 0.98) (0.22, 0.44) (0.05, 0.12) (0.23, 0.47)   (7.90, 15.67) (0.42, 0.86) (0.84, 2.51) (1.31, 3.51) 
Oily Fish Intake2  0.022 - - 0.006 
 
0.044 - - 0.016 
Sex  0.026 - - 0.043 
 
0.054 - - <0.001 
Age3  - 0.031 - - 
 
- - 0.007 - 
BMI4  - - - 0.006   - - - - 
 
                                                                                           DHA 
 
PC NEFAs CEs TGs 
 
PC NEFAs CEs TGs 
  (P) (P) (P) (P)   (P) (P) (P) (P) 
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  % % % %   μg/ml μg/ml μg/ml μg/ml 
Median  2.86 1.1 0.46 0.61 
 
44.13 2.07 9.01 4.28 
(25th, 75th percentile) (2.08, 3.93) (0.80, 1.54) (0.32, 0.61) (0.39, 0.98)   (29.94, 57.68) (1.43, 3.18) (5.88, 12.59) (2.38, 7.19) 
Oily Fish Intake2  <0.001 <0.001 0.001 <0.001 
 
<0.001 0.002 0.045 <0.001 
Sex  - - - - 
 
- - - - 
Age3  0.037 - - - 
 
0.043 - 0.039 0.050 
BMI4  - - - 0.02   - - - - 
EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; PC, phosphatidylcholine; NEFAs, non-esterified fatty 
acids; CEs, cholesteryl esters; TGs, triacyglycerol.       
1 P values obtained using log10 data in univariate general linear model analysis. Individual associations were investigated for by the addition of all 
other variables as covariates, controlling for any associations between confounding variables that may influence the dependant variable. The 
resulting P values are therefore reflective of the sole association between the variable of interest and the dependant variable.     
2 Oily fish intake: 0 portions/week, 0.1-0.99/week, 1.0-1.99/week, and 2+/week. Oily fish defined as: salmon, herring, mackerel, fresh tuna, 
sardines, kippers, and trout.          
3 Age: 20-29y, 30-39y, 40-49y, 50-59y, 60+y.            
4 BMI: Normal weight = 18-25 (kg/m2), Overweight = 25.1-30 (kg/m2) and Obese = 30.1-46 (kg/m2).       
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Table 2 
Statistical significance (P) of the associations between oily fish intake, sex, age, BMI and LC n-3 PUFAs in males and females1   
  
MALES 
  
PC NEFAs CEs TGs 
 
PC NEFAs CEs TGs 
  
P1 P1 P1 P1 
 
P1 P1 P1 P1 
    % % % %   µg/ml µg/ml µg/ml µg/ml 
EPA Oily fish intake2 - - - 0.028 
 
0.062 0.061 - 0.008 
 
Age3 - - - - 
 
- - 0.058 0.019 
  BMI4 - - - 0.014   - - - - 
DPA Oily fish intake2 - - NS - 
 
0.066 0.026 - - 
 
Age3 - - 0.068 - 
 
- - 0.012 - 
  BMI4 - - - -   - - - - 
DHA Oily fish intake2 0.003 0.023 0.016 - 
 
0.002 0.014 - - 
 
Age3 - - 0.011 - 
 
- 0.024 0.005 - 
  BMI4 - - - -   - - - - 
  
FEMALES 
  
PC NEFAs CEs TGs 
 
PC NEFAs CEs TGs 
  
P1 P1 P1 P1 
 
P1 P1 P1 P1 
    % % % %   µg/ml µg/ml µg/ml µg/ml 
EPA Oily fish intake2 0.004 - 0.009 <0.001 
 
0.003 - - <0.001 
 
Age3 0.04 - - - 
 
0.039 - - 0.006 
  BMI4 - - - -   - 0.052 - 0.006 
DPA Oily fish intake2 - - - 0.008 
 
- - - 0.067 
 
Age3 - - - - 
 
- - - - 
  BMI4 - - - -   - - - - 
DHA Oily fish intake2 0.001 0.001 0.003 <0.001 
 
<0.001 0.048 - 0.001 
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Age3 0.035 - - - 
 
0.047 - - 0.032 
  BMI4 - - - -   - 0.010 - - 
EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; PC, phosphatidylcholine; NEFAs, non-esterified fatty 
acids; CEs, cholesteryl esters; TGs, triacyglycerol.  
1 P values obtained using log10 data in univariate general linear model analysis. Individual associations were investigated for by the addition of all 
other variables as covariates, controlling for any associations between confounding variables that may influence the dependant variable. The 
resulting P values are therefore reflective of the sole association between the variable of interest and the dependant variable.     
2 Oily fish intake: 0 portions/week, 0.1-0.99/week, 1.0-1.99/week, and 2+/week. Oily fish defined as: salmon, herring, mackerel, fresh tuna, 
sardines, kippers, and trout.          
3 Age: 20-29y, 30-39y, 40-49y, 50-59y, 60+y.            
4 BMI: Normal weight = 18-25 (kg/m2), Overweight = 25.1-30 (kg/m2) and Obese = 30.1-46 (kg/m2).        
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TABLE 3 
Blood cholesterol (mmol/l) concentration according to sex, age, BMI, APOE genotype and 
oily fish intake 
  TC HDLC LDLC 
  Mean SEM Mean SEM Mean SEM 
Male 5.16 0.08 1.26 0.02 3.34 0.07 
Female 5.16 0.08 1.61 0.03 3.17 0.07 
1P NS 
 
<0.001 
 
NS 
 Age group 
 
 
 
 
  20-29y 4.39 0.14 1.46 0.05 2.56 0.13 
30-39y 4.68 0.1 1.34 0.04 2.93 0.1 
40-49y 5.34 0.11 1.47 0.04 3.41 0.09 
50-59y 5.57 0.1 1.45 0.05 3.62 0.09 
60+y 5.59 0.13 1.49 0.06 3.52 0.1 
2P <0.001 
 
NS 
 
<0.001 
 3BMI group 
      
Normal weight 4.91 0.08 1.57 0.03 2.98 0.07 
Overweight 5.33 0.08 1.34 0.03 3.43 0.07 
Obese 5.63 0.18 1.20 0.05 3.77 0.17 
2P <0.001 
 
<0.001 
 
<0.001 
 APOEgenotype4 
 
 
 
 
  E2 4.71 0.09 1.54 0.04 2.76 0.08 
E3 5.19 0.1 1.43 0.04 3.31 0.08 
E4 5.46 0.08 1.37 0.03 3.57 0.07 
1P <0.001 
 
0.006 
 
<0.001 
 Oily fish intake5 
 
 
 
 
  0/wk 4.9 0.12 1.41 0.04 3.11 0.1 
0.1-0.99/wk 5.21 0.09 1.44 0.03 3.25 0.07 
1-1.99/wk 5.3 0.12 1.48 0.05 3.38 0.1 
2+/wk 5.16 0.15 1.41 0.07 3.28 0.15 
2P NS 
 
NS 
 
NS NS 
TC, Total cholesterol; HDLC, high density lipoprotein cholesterol; LDLC, low density 
lipoprotein cholesterol.  
1P values obtained from one-way ANOVA model.      
2 P values obtained from Pearson's correlation model.      
3 BMI: Normal weight = 18-25 (kg/m2), Overweight = 25.1-30 (kg/m2) and Obese = 30.1-46 
(kg/m2). 
4 APOE genotype: E2 (E2/E2 and E2/E3), E3 (E3/E3), and E4 (E3/E4 and E4/E4) . 
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5 Oily fish defined as: salmon, herring, mackerel, fresh tuna, sardines, kippers, and trout. 
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FIGURE 1 Absolute concentrations (µg/ml) of eicosapentaenoic acid (EPA) in 
phosphatidylcholine (PC), non-esterified fatty acids (NEFAs), cholesteryl esters (CEs) and 
triacylglycerols (TGs) lipid fractions in male and female subjects according to APOE 
genotype. Distribution of participants in each APOE allele group are as follows; PC: Males: 
E2/E2 = 1, E2/E3 = 32, E3/E3 = 40, E3/E4 = 51, and E4/E4 = 2. Total: 126. PC: Females: 
E2/E2 = 3, E2/E3 = 39, E3/E3 = 44, E3/E4 = 43, and E4/E4 = 10. Total: 139. NEFAs: Males: 
E2/E2 = 2, E2/E3 = 29, E3/E3 = 45, E3/E4 = 50, and E4/E4 = 2. Total: 128. NEFAs: Females: 
E2/E2 = 3, E2/E3 = 42, E3/E3 = 44, E3/E4 = 45, and E4/E4 = 10. Total: 144. CEs: Males: 
E2/E2 = 2, E2/E3 = 33, E3/E3 = 50, E3/E4 = 52, and E4/E4 = 2. Total: 139. CEs: Females: 
E2/E2 = 3, E2/E3 = 44, E3/E3 = 48, E3/E4 = 49, and E4/E4 = 10. Total: 154. TGs: Males: 
E2/E2 = 2, E2/E3 = 32, E3/E3 = 50, E3/E4 = 53, and E4/E4 = 2. Total: 139. TGs: Females: 
E2/E2 = 3, E2/E3 = 45, E3/E3 = 49, E3/E4 = 48, and E4/E4 = 10. Total: 155. * P < 0.050, 
and ** P > 0.050 but < 0.060. P values were obtained using log-10 data in univariate general 
linear model (GLM) analysis controlling for covariates (age, BMI, and oily fish intake). 
Where there was a significant association with APOE genotype, significance between specific 
APOE alleles was assessed using parameter estimates obtained from the GLM results. 
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FIGURE 2 Absolute concentrations (µg/ml) of docosapentaenoic acid (DPA) in 
phosphatidylcholine (PC), non-esterified fatty acids (NEFAs), cholesteryl esters (CEs) and 
triacylglycerols (TGs) lipid fractions in male and female subjects according to APOE 
genotype. Distribution of participants in each APOE allele group are as follows; PC: Males: 
E2/E2 = 1, E2/E3 = 32, E3/E3 = 40, E3/E4 = 51, and E4/E4 = 2. Total: 126. PC: Females: 
E2/E2 = 3, E2/E3 = 39, E3/E3 = 44, E3/E4 = 43, and E4/E4 = 10. Total: 139. NEFAs: Males: 
E2/E2 = 2, E2/E3 = 29, E3/E3 = 45, E3/E4 = 50, and E4/E4 = 2. Total: 128. NEFAs: Females: 
E2/E2 = 3, E2/E3 = 42, E3/E3 = 44, E3/E4 = 45, and E4/E4 = 10. Total: 144. CEs: Males: 
E2/E2 = 2, E2/E3 = 33, E3/E3 = 50, E3/E4 = 52, and E4/E4 = 2. Total: 139. CEs: Females: 
E2/E2 = 3, E2/E3 = 44, E3/E3 = 48, E3/E4 = 49, and E4/E4 = 10. Total: 154. TGs: Males: 
E2/E2 = 2, E2/E3 = 32, E3/E3 = 50, E3/E4 = 53, and E4/E4 = 2. Total: 139. TGs: Females: 
E2/E2 = 3, E2/E3 = 45, E3/E3 = 49, E3/E4 = 48, and E4/E4 = 10. Total: 155. * P < 0.050. ** 
P > 0.050 but < 0.070. P values were obtained using log-10 data in univariate general linear 
model (GLM) analysis controlling for covariates (age, BMI, and oily fish intake). Where 
there was a significant association with APOE genotype, significance between specific APOE 
alleles was assessed using parameter estimates obtained from the GLM results. 
 
FIGURE 3 Absolute concentrations (µg/ml) of docosahexaenoic acid (DHA) in 
phosphatidylcholine (PC), non-esterified fatty acids (NEFAs), cholesteryl esters (CEs) and 
triacylglycerols (TGs) lipid fractions in male and female subjects according to APOE 
genotype. Distribution of participants in each APOE allele group are as follows; PC: Males: 
E2/E2 = 1, E2/E3 = 32, E3/E3 = 40, E3/E4 = 51, and E4/E4 = 2. Total: 126. PC: Females: 
E2/E2 = 3, E2/E3 = 39, E3/E3 = 44, E3/E4 = 43, and E4/E4 = 10. Total: 139. NEFAs: Males: 
E2/E2 = 2, E2/E3 = 29, E3/E3 = 45, E3/E4 = 50, and E4/E4 = 2. Total: 128. NEFAs: Females: 
E2/E2 = 3, E2/E3 = 42, E3/E3 = 44, E3/E4 = 45, and E4/E4 = 10. Total: 144. CEs: Males: 
E2/E2 = 2, E2/E3 = 33, E3/E3 = 50, E3/E4 = 52, and E4/E4 = 2. Total: 139. CEs: Females: 
E2/E2 = 3, E2/E3 = 44, E3/E3 = 48, E3/E4 = 49, and E4/E4 = 10. Total: 154. TGs: Males: 
E2/E2 = 2, E2/E3 = 32, E3/E3 = 50, E3/E4 = 53, and E4/E4 = 2. Total: 139. TGs: Females: 
E2/E2 = 3, E2/E3 = 45, E3/E3 = 49, E3/E4 = 48, and E4/E4 = 10. Total: 155. * P = 0.021. P 
values were obtained using log-10 data in univariate general linear model (GLM) analysis 
controlling for covariates (age, BMI, and oily fish intake). Where there was a significant 
association with APOE genotype, significance between specific APOE alleles was assessed 
using parameter estimates obtained from the GLM results.  
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